Western Europe Companion Animal Healthcare Market, by End User, 2018-2027
Western Europe Companion Animal Healthcare Market, by Diagnostics, 2018-2027
By Diagnostics, the market is segmented into Diagnostic Imaging , Immunodiagnostic Tests, Molecular Diagnostics, and Others (2018–2027)
| Label | Diagnostic Imaging | Immunodiagnostic Tests | Molecular Diagnostics | Others |
|---|---|---|---|---|
| 2018 | 191.31 USD Mn | 150.32 USD Mn | 100.01 USD Mn | 192.8 USD Mn |
| 2019 | 202 USD Mn | 161.31 USD Mn | 105.8 USD Mn | 204.77 USD Mn |
| 2020 | 211.15 USD Mn | 171.35 USD Mn | 110.8 USD Mn | 215.31 USD Mn |
| 2021 | 224.27 USD Mn | 184.95 USD Mn | 117.92 USD Mn | 230.06 USD Mn |
| 2022 | 238.62 USD Mn | 199.95 USD Mn | 125.71 USD Mn | 246.25 USD Mn |
| 2023 | 254.33 USD Mn | 216.54 USD Mn | 134.26 USD Mn | 264.04 USD Mn |
| 2024 | 271.55 USD Mn | 234.9 USD Mn | 143.64 USD Mn | 283.64 USD Mn |
| 2025 | 290.46 USD Mn | 255.27 USD Mn | 153.96 USD Mn | 305.25 USD Mn |
| 2026 | 311.28 USD Mn | 277.91 USD Mn | 165.33 USD Mn | 329.14 USD Mn |
| 2027 | 334.22 USD Mn | 303.11 USD Mn | 177.88 USD Mn | 355.58 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Western Europe Companion Animal Healthcare Market, by Diagnostics, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 1084 Mn in 2026 and is projected to reach USD 1171 Mn by 2027 — a gain of about 8% over the forecast period, translating to a CAGR in the high single digits.
- 2027: Others leads this comparison at 355. 58M USD — 30% of the combined total across all 4 groups shown.
- What the regional split looks like (2026): Others leads, holding roughly 30% of segment value — the single largest regional share. Diagnostic Imaging is the second-largest contributor. Immunodiagnostic Tests and Molecular Diagnostics make up the remainder, in descending order.
- By 2027, Others alone is expected to reach USD 356 Mn, with Diagnostic Imaging at USD 334 Mn.
Market Dynamics
2027: Others leads this comparison at 355.58M USD — 30% of the combined total across all 4 groups shown.
Next is Diagnostic Imaging, at 334.22M USD — 6% behind Others.
Others grows to 355.58M USD by 2027, from 192.80M USD in 2018 — 84% up.
Diagnostic Imaging: 191.31M USD to 334.22M USD, 75% higher by 2027.
Immunodiagnostic Tests: 150.32M USD in 2018 to 303.11M USD by 2027, up 102%.
Molecular Diagnostics climbs from 100.01M USD (2018) to 177.88M USD (2027), a 78% gain.
Immunodiagnostic Tests outpaces every other series here, 102% growth — worth watching even if it is not the biggest in absolute terms yet.
Across the full group, the combined total moves from 634.44M USD in 2018 to 1.17B USD in 2027 — a 85% change.
How The 4 Series Compare
This chart compares 4 series side by side, not one trend over time. Read them against each other — the biggest number in the room is not automatically the most important line to follow.
The largest series today is not guaranteed to stay largest — check the growth rate of each group, not just its current size, before projecting the ranking forward.
The most practical way to read this is relative: set the Western Europe Companion Animal Healthcare market figures beside other regions or segments of the same market to see where growth is concentrated.
This is a market research forecast, not an official statistic. Values after the 2018 base year are modeled projections to 2027, based on supply-side and demand-side analysis, and are updated when market conditions change.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Related Charts
View AllWestern Europe Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027
Western Europe Companion Animal Healthcare Market, by Feed Additives, 2018-2027
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



